AMICUS THERAPEUTICS, INC. — Director's Dealing 2015

Apr 13, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-04-10

Reporting Person: Crowley John F (Director, Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-04-10	Common Stock	M	11678	$12.00	Acquired	95177	Direct
2015-04-10	Common Stock	S	11678	$12.00	Disposed	83499	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-04-10	Stock Options (right to buy)	$5.325	M	11678	Disposed	2016-02-28	Common Stock (11678)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	64895	Indirect

Footnotes

F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.